Skip to main content

Accuray Incorporated (ARAY) Stock Forecast

Data as of Aug 8, 2026

Healthcare · Current price $0.29 (+2.62%)

Consensus Target
$2.00
Upside
+628.3%
Analysts
2
Rating
Hold(3.00)

Price Target Range

Low $2.00High $2.00

Consensus Price Target Over Time

Analyst Rating Distribution

Last 3 Months

Consensus
Hold
Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0

6-Month Trend

Latest Analyst Forecasts

Price targets issued by Wall Street analysts. Upside calculated against today's price.

DateAnalystFirmPrice TargetUpside
May 2, 2024Maria ThibaultBTIG$6.00+1968.3%

ARAY vs Sector & Market

MetricARAYHealthcare AvgLarge Cap Avg
Analyst Rating3.002.252.42
Analyst Count2818
Target Upside+628.3%+16315.4%+17.2%
P/E Ratio-1.463.5936.06

Revenue Estimates

PeriodLowAvgHigh#
2027-06-30$462M$463M$465M1
2028-06-30$483M$483M$483M1

EPS Estimates

PeriodLowAvgHigh#
2027-06-30$-0.01$-0.01$-0.011
2028-06-30$0.12$0.12$0.121

Frequently Asked Questions

What is the analyst consensus for ARAY?

The consensus among 2 analysts covering Accuray Incorporated (ARAY) is Hold with an average price target of $2.00.

What is the highest price target for ARAY?

The highest price target for ARAY is $6.00, set by Maria Thibault at BTIG on 2024-05-02.

What is the lowest price target for ARAY?

The lowest price target for ARAY is $6.00, set by Maria Thibault at BTIG on 2024-05-02.

How many analysts cover ARAY?

2 analysts have issued ratings for Accuray Incorporated in the past 12 months.

Is ARAY a buy or sell right now?

Based on 2 analyst ratings, ARAY has a consensus rating of Hold (3.00/5) with a +628.3% upside to the consensus target of $2.00.

What are the earnings estimates for ARAY?

Analysts estimate ARAY will report EPS of $-0.01 for the period ending 2027-06-30, with revenue estimated at $463M.

Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.